Prevalence of Obstructive Sleep Apnea in Patients With Peripheral Arterial Occlusive Disease

Sponsor
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Study ID
NCT07283289
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Obstructive sleep apnea syndrome (OSAS) is characterized by partial (hypopnea) or complete (apnea) obstruction of the upper airways, leading to intermittent hypoxemia and sleep fragmentation. Peripheral arterial occlusive disease (PAOD) is a chronic condition defined by the narrowing or occlusion of arteries in the lower limbs, often resulting in ischemia of downstream tissues. This disease is a common complication of atherosclerosis and affects approximately 1.2% of the general French population. OSAS is a well-established risk factor for atherosclerotic disease, particularly for coronary and neurovascular events. Although a relationship between OSAS and PAOD has been investigated in recent years, the link has not been definitively established and requires further study. Therefore, this preliminary cohort study aims to observe the prevalence of OSAS among patients diagnosed with PAOD, regardless of the disease stage.

Key Dates

First listed
Dec 15, 2025
Start date
Nov 5, 2025
Status verified
Jul 2026
Primary completion
Nov 30, 2026
Completion
Nov 30, 2026

Study Design

Enrollment
295 participants (estimated)

Arms

  • Arm: Patients with PAOD
    Patients hospitalized or seen in vascular medicine consultation with a diagnosis of PAOD at all stages (operated or not) according to the Leriche and Fontaine classification.

Primary Outcome Measure

Proportion of patients diagnosed with OSAS [ Time Frame: Up to 1 month ]

Central Contacts

Find similar trials

Nationwide
Peripheral artery disease trialsCardiology trialsVascular medicine trials

Related Studies